{"id":"W2017082986","doi":"10.1038/sj.bjc.6603419","title":"A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas","year":2006,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Temsirolimus; Medicine; Pharmacodynamics; Rash; Internal medicine; Sirolimus; Everolimus; Adverse effect; Oncology; Pharmacology; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology; Pharmacokinetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002209364,0.0001412423,0.0007195438,0.0002534055,0.00004668181,0.00001546741,0.0001405678,0.000006174901,0.00005469594],"category_scores_gemma":[0.0002008323,0.0001461101,0.0001089716,0.0002975714,0.0001649056,0.0002254577,0.00008772993,0.0006752887,2.790644e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000049806,"about_ca_system_score_gemma":0.000178428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001391107,"about_ca_topic_score_gemma":0.002726883,"domain_scores_codex":[0.997533,0.0001704838,0.001163791,0.0002450795,0.0005457942,0.0003418884],"domain_scores_gemma":[0.9988829,0.0001074121,0.0004080173,0.0001292362,0.0002684082,0.0002040237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00478139,0.01220163,0.5985174,0.0001811056,0.0001088099,0.1072108,0.00004397093,0.0002594644,0.01529796,0.000005050479,0.0006610373,0.2607314],"study_design_scores_gemma":[0.1076803,0.01993638,0.8179324,0.0006809371,0.000227643,0.04192047,0.00031616,0.0003731495,0.002938264,0.00009863453,0.007672654,0.0002230837],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879664,0.01066317,0.000001776021,0.0003395648,0.0002356169,0.0005761837,0.00001616748,0.000009166039,0.0001919676],"genre_scores_gemma":[0.9944215,0.004653357,0.0001105269,0.00009505322,0.0002999403,0.00001813572,0.000001070492,0.00002979692,0.0003706284],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2605083,"threshold_uncertainty_score":0.5958198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02542672549639566,"score_gpt":0.4100298367940532,"score_spread":0.3846031112976576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}